MedTrace Logo

Group Metacognitive Therapy vs Clinical Management for Depression

NCT03711123 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2018-10-18

No results posted yet for this study

Summary

The main aims of the study are to (1) compare the effectiveness of Group metacognitive therapy (GMCT) treatment to that of clinical management and (2) explore patterns of change and investigate factors associated with treatment outcome

Conditions

Interventions

BEHAVIORAL

Group metacognitive therapy

10 weekly Group session of 90 minutes duration

BEHAVIORAL

Clinical management

10 weekly individual sessions With clinical management including guided self-help

Sponsors & Collaborators

  • University of Oslo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2021-04-30
Completion
2025-06-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03711123 on ClinicalTrials.gov